Crosslinkable biological material and medical uses

Details Crosslinkable biological material and medical uses Crosslinkable biological material and medical uses

2006-09-05

2006-09-05

Jiang, Shaojia (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C424S423000, C424S445000, C435S325000

Reexamination Certificate

active

07101857

ABSTRACT:
A method for promoting angiogenesis in a patient comprising providing crosslinkable biological solution to the target tissue, wherein the crosslinkable biological solution is loaded with at least one angiogenic agent. In one embodiment, the at least one angiogenic agent is a non-protein factor selected from a group consisting of ginsenoside Rg1, ginsenoside Re, combination thereof and the like. In another embodiment, the crosslinkable biological solution of the present invention is broadly defined in a form or phase of solution, paste, gel, suspension, colloid or plasma that may be solidifiable thereafter.

REFERENCES:
patent: 4806595 (1989-02-01), Noishiki et al.
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 5270446 (1993-12-01), Kyogoku et al.
patent: 5332935 (1994-07-01), Smith
patent: 5573784 (1996-11-01), Badylak et al.
patent: 5663160 (1997-09-01), Meybeck et al.
patent: 5874417 (1999-02-01), Prestwich et al.
patent: 5929038 (1999-07-01), Chang
patent: 6051750 (2000-04-01), Bell
patent: 6103255 (2000-08-01), Levene et al.
patent: 6162826 (2000-12-01), Moon et al.
patent: 6262083 (2001-07-01), Moon et al.
patent: 6264992 (2001-07-01), Voytik-Harbin et al.
patent: 6340480 (2002-01-01), Duckett et al.
patent: 6485723 (2002-11-01), Badylak et al.
patent: 6506398 (2003-01-01), Tu et al.
patent: 6545042 (2003-04-01), Sung et al.
patent: 6608040 (2003-08-01), Lin et al.
patent: 6624138 (2003-09-01), Sung et al.
patent: 406239759 (1994-08-01), None
patent: WO 94/17227 (1994-08-01), None
Malone et al, J. Vasc. Surg. 1984, 1, 181-191.
Courtman et al, J. Biomedical Materials Research, 1994, 28, 655-661.
Morisaki et al , British Journal of Pharmacology, 1995, 115, 1186-93.
Malone et al , J. Vasc. Surg., 1984, 1, 181-191.
Sung HW et al., J Biomed Mater Res 1998; 42 : 560-567.
Huang LLH et al., J Biomed Mater Res 1998; 42 : 568-576.
Sung HW et al., J Biomater Sci Polymer Edn 1998; 10(1): 63-78.
Sung HW et al., J Biomater Sci Polymer Edn 1999; 10 (7): 751-771.
Sung HW et al., J Biomed Mater Res 1999; 46 : 520-530.
Sung HW et al., J Biomed Mater Res 1999; 47 : 116-126.
Sung H W et al., Biomaterials 1998; 20 : 1759-1772.
Sung HW et al., Biomaterials 2001; 21 : 1353-1362.
Tsai CC et al., J Biomed Mater Res 2000; 52 : 58-65.
Mi FL et al., J Polym Sci A : Polym Chem 2000; 58 : 2804-2814.
Tsai CC et al., Biomaterials 2001; 22 : 523-533.
Mi FL et al., J Appl Polym Sci 2001;81 : 1700-1711.
Sung HW et al., J Biomed Mater Res 2001; 55 : 538-546.
Mi FL et al., J Biomater Sci Polymer Edn 2001; 12(8) : 835-850.
Mi FL et al., Biomaterials 2002; 23 : 181-191.
Mi FL et al., Carbohydrate Polymers 2002; 48 : 61-72.
Chang Y et al., Biomaterials 2002; 23 : 2447-2457.
Liang HC et al., J. Biomed Mater Res 2003; 65A : 271-282.

Affiliated with

Also associated with

Rating

Crosslinkable biological material and medical uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crosslinkable biological material and medical uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crosslinkable biological material and medical uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3527171